Reaction

Mitral Valve Thickening reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 274 reports · 8 co-occurring drugs

As of the last recalculation, Mitral Valve Thickening appears in 274 FAERS reports alongside 8 co-occurring drug terms. The strongest observed disproportionality signal is EPLERENONE (PRR 134.8).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Eplerenone21134.8135.1
Methoxy Polyethylene Glycol-Epoetin Beta1393.994.0
Sevelamer Carbonate1390.290.3
Cannabidiol1758.858.8
Dapagliflozin2154.854.9
Clobazam1445.945.9
Cenobamate436.937.0
Brivaracetam434.334.3

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.